The pathogenesis of infant leukemia involves a prenatal genetic lesion - frequently MLL (KMT2A) gene rearrangement - combined with postnatal events, such as epigenetic dysregulation, aberrant immune responses to infection, or additional somatic mutations that trigger full leukemogenesis [5,6]. The gene discussed is KMT2A; the disease is infection.